SMMT
Summit Therapeutics Inc. Common Stock
stockNASDAQ
At CloseNov 6, 2026 3:59:58 PM EST
16.34USD+15.152%(+2.15)5,781,074
Pre-marketNov 6, 2026 9:28:30 AM EST
14.79USD+4.228%(+0.60)
After-hoursNov 6, 2026 4:57:30 PM EST
16.29USD-0.306%(-0.05)
Loading…
Loading…
13.03B
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$14.19
Beta
1.82
52-Week High
$29.23 2026-04-21
52-Week Low
$12.07 2026-08-17
SMA 50
$16.21
SMA 200
$16.15
Avg. Vol 10D
4.41M
Avg. Vol 30D
6.20M
Avg. Vol 90D
5.47M
Relative Vol
0.76
797.75M
110.35M
13.83%
40,896,653
37.06%
7.02
56%/44%
57.76%
36.45%
0.4500%
10,000,000
7,167
128,992
1,094,668
-832.7M
-1.07
-526.9M
-220.01
Nov 6, 2026
Nov 5, 2026
Stifel cuts Summit Therapeutics stock price target on valuation · 
Investing.com
UK car market up 5.4% in October · 
Just Auto
Nov 4, 2026
SMMT Profile
summit is a uk company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need. our strategy focuses on two therapy areas: duchenne muscular dystrophy, a fatal genetic muscle wasting disease and the infectious disease caused by the bacteria c. difficile.
SMMT Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 16.03 | 2026-10-30 | +1.90% | 2.735 |
| 1M | 17.31 | 2026-10-06 | -5.63% | 2.501 |
| 3M | 13.54 | 2026-08-06 | +20.64% | 2.381 |
| 6M | 17.85 | 2026-05-06 | -8.49% | 1.814 |
| 1Y | 18.45 | 2025-11-06 | -11.46% | 1.822 |
| 2Y | 20.89 | 2024-11-06 | -21.80% | — |
| 5Y | 5.64 | 2021-11-05 | +189.63% | 0.840 |
SMMT Stock Summary
Summit Therapeutics Inc. Common Stock (NASDAQ:SMMT) stock price today is $16.34, and today's volume is 4,714,198. SMMT is up 15.116% today. The 30 day average volume is 6.20M. SMMT market cap is $13.03B with 797.75M shares outstanding.